Pharmaceuticals · PH-04 · Moving to EU GMP: the electronic batch record
A paper batch record is the inspector's first question.
At a presidential meeting it was stated that all 58 manufacturers hold national GMP certification and now need to meet EU GMP requirements. From 1 June, 50% of the cost of obtaining EU GMP certification will be reimbursed. Internationally, the electronic batch record (eBR) is the main tool for this transition.
Platform: Plant Pulse
Enterprises that directly manufacture medicines; all hold national GMP certification.1
Share of EU GMP certification costs to be reimbursed (from 1 June).1
Share of enterprises with international GMP certification, according to Anhor.2
EU GMP is not a document; it is a traceable record of every batch.
Who it is for
- CEO
- Exports and certification.
- Quality Director (QA)
- Batch release.
- Production
- Execution.
- IT
- Validation.
Where the problem lies
Manual records
Weighing results and calculations are written by hand.
Signatures
Signatures and their time sequence cannot be verified.
Review
QA reads every page, so batch release is delayed.
Audit trail
There is no change history.
How the loss is calculated
| Release delay | release delay (days) × batch value × daily cost of capital (annual rate ÷ 365) |
|---|---|
| Deviations | review hours × QA hourly cost |
| Rejected batch | batch value |
| Inspection | preparation cost |
Calculate with your data
Batch Release Delay: Cost of Tied-Up Capital
This calculator estimates the annual cost of capital tied up in finished batches while they wait for QA release.
Use spaces for thousands and a dot or comma for decimals. Use the same currency throughout.
Values stay in this page and are not sent to the server.
Scenario estimate
0 / 5 values entered
Enter your operating figures to see the estimate.
Results are estimates only, not promises or guarantees. Enter batch value at cost, not at selling price. Use your company's actual annual cost-of-capital rate. The calculator does not guarantee an exact timeline or price, a GMP/GDP certificate, an inspection outcome or approval of validation documents. The target release time is a scenario you choose; it has not been measured and is not guaranteed to be achieved. The real effect can only be established through an audit and process measurement. A full eBR/MES system is delivered by a partner.
Formulas and assumptions
This calculator estimates the annual cost of capital tied up in finished batches while they wait for QA release. Calculation: days × batch cost value × cost of capital. Your current release time is compared with a target release time that you set yourself. You may link the target to electronic batch records (eBR), but it is not presented as an achievable result. All values are annual and expressed in the currency unit you use. Deviation investigation hours, rejected batches, inspection preparation, storage, insurance and system implementation costs are excluded.
- Current state: annual cost of tied-up capital
- Batches per year × batch cost value (currency unit) × current release time (days) × (cost of capital % ÷ 100 ÷ 365 days).
- Scenario: annual cost of tied-up capital at target time
- Same formula as the current state, but using your target release time (days) instead of the current one.
- Difference between current state and scenario (estimate)
- Batches per year × batch cost value × (current days − target days) × (cost of capital % ÷ 100 ÷ 365). If the target is longer than the current time, the result is 0. This is not a guaranteed saving.
- Current state: average value of stock awaiting release
- (Batches per year ÷ 365 days) × current release time (days) × batch cost value (currency unit). This is the stock value sitting in quarantine at any given time. It is not an annual cost and must not be added to the results above.
Facts and global practice
Presidential meeting
More than 300 pharmaceutical enterprises, of which 58 directly manufacture medicines; all hold national GMP certification; they now need to align with EU GMP.1
Presidential meeting
From 1 June, 50% of the costs of obtaining EU GMP certification will be reimbursed from the Trade Promotion Fund.1
anhor.uz
Only 12% of enterprises hold international GMP certification.2
Siemens; Reliamag
Siemens Opcenter Execution Pharma and Körber PAS-X offer electronic batch recording and a review-by-exception approach (reviewing only deviations).3
Körber
Statement by a Körber representative: PAS-X EBR has improved product and process quality by up to 98% at many customers.4
The Körber figure is a vendor claim. Large eBR systems are expensive and take a long time to implement; smaller plants need a phased approach.
Phased eBR
Phase one: electronic records and audit trail for weighing, materials and batches. Where a full MES/eBR system is required, it is delivered with a partner vendor.
- 01Materials
- Receipt
- Quarantine
- Approval
- 02Weighing
- Scale
- Recipe
- Signature
- 03Execution
- Steps
- Deviations
- Time
- 04Release
- QA review
- Audit trail
- Archive
Modules
The current maturity level is shown next to each module.
| Materials and quarantine (WMS) | GMP statuses | Commercially available |
|---|---|---|
| Weighing and dispensing record | Scale integration | Engineering capability |
| Deviation log and audit trail | Electronic | Engineering capability |
| Full eBR/MES | Partner | In development |
How we start
- 01
GMP gap audit
Paper records and systems.
Outcome: Gap map.
- 02
Materials and weighing
One product.
Outcome: Electronic record.
- 03
Deviations
With QA.
Outcome: Review by exception.
- 04
Validation
With a partner.
Outcome: Inspection readiness.
What is measured
| Batch release time | Days | System |
|---|---|---|
| Deviations | Count | Log |
| Manual entries | Share | Audit |
| Audit trail completeness | % | System |
What is needed to start
- QA Director
- Sample batch record
- List of scales
- Validation requirements
What we do not promise
- Fixed timeline and price without an audit
- GMP/GDP certification or inspection outcome
- Approval of validation documents by us
- Unmeasured results
- Full eBR/MES (partner)
Self-check
- Is the batch record electronic?
- Are weighing results transferred automatically from the scale?
- Is there an audit trail for every change?
- Are electronic signatures used?
- Does QA review only deviations?
- Is material quarantine managed in the system?
- Is batch release time (in days) recorded?
- Has a reimbursement application been submitted?
- Has a consultant been selected?
- Is there a designated responsible person?
GMP gap audit
We review the batch record and materials processes and identify where they fall short of EU GMP.
- Map of breakpoints
- Pilot plan
- Implementation fee and monthly subscription
Other solutions in this industry
- PH-01GDP warehouse: temperature and batch data in one system
- PH-02Shelf life and FEFO
- PH-03Warehouse operations with marking codes
- PH-05Plant warehouse: quarantine, release and raw materials
- PH-06Compliance with reference prices
- PH-07Reimbursement: prescription, code, receipt and ESF
- PH-08Quality control laboratory and data integrity
- PH-09Imported medicines warehouse and customs requirements
- PH-10Packaging line productivity
Sources
- Presidential video conference: expanding production in the pharmaceutical industry. president.uz, 05.03.2026.
- «12% of pharmaceutical enterprises in Uzbekistan meet international standards». anhor.uz.
- Siemens Xcelerator: «Review by Exception» (Opcenter Execution Pharma). xcelerator.siemens.com. Reliamag: «Best MES for Pharmaceutical Manufacturing 2026: an independent comparison». 2026.
- Körber: «Boosting efficiency and productivity with Electronic Batch Recording». koerber.com.